BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 15280447)

  • 1. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
    Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
    Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
    Huang SC
    Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
    Riewald M; Petrovan RJ; Donner A; Ruf W
    J Endotoxin Res; 2003; 9(5):317-21. PubMed ID: 14577849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
    Huang SC
    Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
    Greenberg DL; Mize GJ; Takayama TK
    Biochemistry; 2003 Jan; 42(3):702-9. PubMed ID: 12534282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells.
    Fang Y; Ferrie AM
    BMC Cell Biol; 2007 Jun; 8():24. PubMed ID: 17587449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells.
    Kamath L; Meydani A; Foss F; Kuliopulos A
    Cancer Res; 2001 Aug; 61(15):5933-40. PubMed ID: 11479236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin affects eosinophil migration via protease-activated receptor-1.
    Feistritzer C; Mosheimer BA; Kaneider NC; Riewald M; Patsch JR; Wiedermann CJ
    Int Arch Allergy Immunol; 2004 Sep; 135(1):12-6. PubMed ID: 15286440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells.
    Nakayama T; Hirano K; Shintani Y; Nishimura J; Nakatsuka A; Kuga H; Takahashi S; Kanaide H
    Br J Pharmacol; 2003 Jan; 138(1):121-30. PubMed ID: 12522081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PAR1-targeted ligands.
    Kawabata A; Saifeddine M; Al-Ani B; Leblond L; Hollenberg MD
    J Pharmacol Exp Ther; 1999 Jan; 288(1):358-70. PubMed ID: 9862790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway.
    Chen HT; Tsou HK; Tsai CH; Kuo CC; Chiang YK; Chang CH; Fong YC; Tang CH
    J Cell Physiol; 2010 Jun; 223(3):737-45. PubMed ID: 20175118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways.
    Liu Y; Mueller BM
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1263-70. PubMed ID: 16650817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of protease-activated receptors in the human submucous plexus.
    Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M
    Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells.
    Loberg RD; Tantivejkul K; Craig M; Neeley CK; Pienta KJ
    J Cell Biochem; 2007 Aug; 101(5):1292-300. PubMed ID: 17492768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells.
    Zhou H; Hu H; Shi W; Ling S; Wang T; Wang H
    Oncol Rep; 2008 Nov; 20(5):1069-76. PubMed ID: 18949403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors.
    Altrogge LM; Monard D
    Anal Biochem; 2000 Jan; 277(1):33-45. PubMed ID: 10610687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment.
    Elzer KL; Heitzman DA; Chernin MI; Novak JF
    Integr Cancer Ther; 2008 Dec; 7(4):282-94. PubMed ID: 19116224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.